NGM logo

NGM Biopharmaceuticals (NGM) Free Cash Flow

Annual FCF

-$133.45 M
+$12.84 M+8.78%

December 31, 2023

Summary

Performance

1-Year Change

+8.78%

3-Year Change

-56.32%

5-Year Change

-892.89%

15-Year Change

-459.91%

NGM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$13.44 M

3-Year Low

-$146.30 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
NGM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
NGM next annual earnings announcement has not yet been scheduled

OtherNGMcash flowmetrics:

Annual CFO

-$132.20 M
NGM annual cash flow from operations is -$132.20 million

Annual CFF

$1.77 M
NGM annual cash flow from financing activities is $1.77 million

Annual CFI

$114.29 M
NGM annual cash flow from investing activities is $114.29 million

Annual CAPEX

$1.25 M
NGM annual capital expenditures is $1.25 million

Quarterly FCF

-$23.15 M
+$4.30 M+15.67%

December 31, 2023

Summary

Performance

3-Month Change

+15.67%

1-Year Change

+45.52%

3-Year Change

-13.97%

5-Year Change

-435.47%

NGM Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$6.90 M
NGM quarterly free cash flow is currently -435.47% below its historical high of $6.90 million

3-Year Low

-$50.97 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
NGM previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

N/A
NGM next earnings announcement has not yet been scheduled

OtherNGMcash flowmetrics:

Quarterly CFO

-$22.96 M
NGM quarterly cash flow from operations is -$22.96 million

Quarterly CFF

$111.00 K
NGM quarterly cash flow from financing activities is $111.00 thousand

Quarterly CFI

$27.19 M
NGM quarterly cash flow from investing activities is $27.19 million

Quarterly CAPEX

$188.00 K
NGM quarterly capital expenditures is $188.00 thousand

TTM FCF

-$133.45 M
+$7.69 M+5.45%

December 31, 2023

Summary

Performance

3-Month Change

+5.45%

1-Year Change

+12.64%

3-Year Change

-56.32%

5-Year Change

-198.8%

NGM TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$5.50 M

3-Year Low

-$152.77 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
NGM previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

N/A
NGM next earnings announcement has not yet been scheduled

OtherNGMcash flowmetrics:

TTM CFO

-$132.20 M
NGM TTM cash flow from operations is -$132.20 million

TTM CFF

$1.77 M
NGM TTM cash flow from financing activities is $1.77 million

TTM CFI

$114.29 M
NGM TTM cash flow from investing activities is $114.29 million

TTM CAPEX

$1.25 M
NGM TTM capital expenditures is $1.25 million

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$133.45 M
NGM annual free cash flow is -$133.45 million

Annual CFO

-$132.20 M
NGM annual cash flow from operations is -$132.20 million

Annual CAPEX

$1.25 M
NGM annual capital expenditures is $1.25 million

NGM Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.8%+45.5%+12.6%
3 y3 years-56.3%-14.0%-56.3%
5 y5 years-892.9%-435.5%-198.8%

NGM Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+78.1%+9.6%+25.4%+120.2%+78.1%+14.5%
5 y5-year+198.8%+9.6%+142.3%+120.2%+198.8%+14.5%
alltimeall time+892.9%+9.6%-435.5%+120.2%+2327.3%+14.5%

NGM Biopharmaceuticals Free Cash Flow History

DateAnnualQuarterlyTTM
Dec 2023
-$133.45 M(-8.8%)
-$23.15 M(-15.7%)
-$133.45 M(-5.5%)
Sep 2023
-
-$27.45 M(-32.0%)
-$141.15 M(-0.7%)
Jun 2023
-
-$40.35 M(-5.0%)
-$142.15 M(-7.0%)
Mar 2023
-
-$42.50 M(+37.8%)
-$152.77 M(+4.4%)
Dec 2022
-$146.30 M(+95.3%)
-$30.84 M(+8.4%)
-$146.30 M(+9.2%)
Sep 2022
-
-$28.46 M(-44.2%)
-$133.92 M(+16.4%)
Jun 2022
-
-$50.97 M(+41.5%)
-$115.02 M(+29.9%)
Mar 2022
-
-$36.02 M(+95.1%)
-$88.55 M(+18.2%)
Dec 2021
-$74.91 M(-12.3%)
-$18.47 M(+93.3%)
-$74.91 M(-2.4%)
Sep 2021
-
-$9.55 M(-61.0%)
-$76.76 M(-17.0%)
Jun 2021
-
-$24.50 M(+9.5%)
-$92.53 M(+5.0%)
Mar 2021
-
-$22.39 M(+10.2%)
-$88.08 M(+3.2%)
Dec 2020
-$85.38 M
-$20.31 M(-19.8%)
-$85.38 M(+5.8%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$25.32 M(+26.2%)
-$80.72 M(+29.7%)
Jun 2020
-
-$20.06 M(+2.0%)
-$62.25 M(+23.3%)
Mar 2020
-
-$19.68 M(+25.6%)
-$50.47 M(+13.0%)
Dec 2019
-$44.66 M(+232.3%)
-$15.66 M(+128.6%)
-$44.66 M(+102.1%)
Sep 2019
-
-$6.85 M(-17.3%)
-$22.10 M(+1.5%)
Jun 2019
-
-$8.29 M(-40.2%)
-$21.78 M(-0.2%)
Mar 2019
-
-$13.87 M(-300.9%)
-$21.81 M(+62.3%)
Dec 2018
-$13.44 M(-43.6%)
$6.90 M(-205.8%)
-$13.44 M(-33.9%)
Sep 2018
-
-$6.53 M(-21.6%)
-$20.34 M(+47.2%)
Jun 2018
-
-$8.32 M(+51.3%)
-$13.82 M(+151.3%)
Mar 2018
-
-$5.50 M
-$5.50 M
Dec 2017
-$23.84 M(+1.3%)
-
-
Dec 2016
-$23.54 M
-
-

FAQ

  • What is NGM Biopharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for NGM Biopharmaceuticals?
  • What is NGM Biopharmaceuticals annual FCF year-on-year change?
  • What is NGM Biopharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for NGM Biopharmaceuticals?
  • What is NGM Biopharmaceuticals quarterly FCF year-on-year change?
  • What is NGM Biopharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for NGM Biopharmaceuticals?
  • What is NGM Biopharmaceuticals TTM FCF year-on-year change?

What is NGM Biopharmaceuticals annual free cash flow?

The current annual FCF of NGM is -$133.45 M

What is the all time high annual FCF for NGM Biopharmaceuticals?

NGM Biopharmaceuticals all-time high annual free cash flow is -$13.44 M

What is NGM Biopharmaceuticals annual FCF year-on-year change?

Over the past year, NGM annual free cash flow has changed by +$12.84 M (+8.78%)

What is NGM Biopharmaceuticals quarterly free cash flow?

The current quarterly FCF of NGM is -$23.15 M

What is the all time high quarterly FCF for NGM Biopharmaceuticals?

NGM Biopharmaceuticals all-time high quarterly free cash flow is $6.90 M

What is NGM Biopharmaceuticals quarterly FCF year-on-year change?

Over the past year, NGM quarterly free cash flow has changed by +$19.35 M (+45.52%)

What is NGM Biopharmaceuticals TTM free cash flow?

The current TTM FCF of NGM is -$133.45 M

What is the all time high TTM FCF for NGM Biopharmaceuticals?

NGM Biopharmaceuticals all-time high TTM free cash flow is -$5.50 M

What is NGM Biopharmaceuticals TTM FCF year-on-year change?

Over the past year, NGM TTM free cash flow has changed by +$19.32 M (+12.64%)